Magnetic Resonance Imaging of Iron in Parkinsons Disease
Journal:
Current Medical Imaging
Volume:
1
Page:
43-48
Author(s):
Kazuo Abe and Tachio Hikita
Subject Index to Volume 10
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
101-142
Author(s):
Bentham Science Publishers
Partial Dopamine Agonists and the Treatment of Psychosis
Journal:
Current Neuropharmacology
Volume:
3
Page:
3-8
Author(s):
Carol A. Tamminga
Novel Potential Therapeutics for Schizophrenia: Focus on the Modulation of Metabotropic Glutamate Receptor Function
Journal:
Current Neuropharmacology
Volume:
3
Page:
9-34
Author(s):
Laura E. Chavez-Noriega, Michael J. Marino, Herve Schaffhauser, Una C. Campbell and P. Jeffrey Conn
Glycine Site Modulators and Glycine Transporter-1 Inhibitors as Novel Therapeutic Targets for the Treatment of Schizophrenia
Journal:
Current Neuropharmacology
Volume:
3
Page:
35-43
Author(s):
Gene G. Kinney and Cyrille Sur
Selective Targeting of Muscarinic Receptors: Novel Therapeutic Approaches for Psychotic Disorders
Journal:
Current Neuropharmacology
Volume:
3
Page:
63-71
Author(s):
Cyrille Sur and Gene G. Kinney
Gender Differences in Pharmacokinetics and Side Effects of Second Generation Antipsychotic Drugs
Journal:
Current Neuropharmacology
Volume:
3
Page:
73-85
Author(s):
W. Aichhorn, M. Gasser, E. M. Weiss, C. Adlassnig and J. Marksteiner
Subject Index to Volume 4
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
91-105
Author(s):
Bentham Science Publishers
The Neuronal Cytoskeleton as a Potential Therapeutical Target in Neurodegenerative Diseases and Schizophrenia
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
3
Page:
515-533
Author(s):
G. Benitez-King, G. Ramirez-Rodriguez, L. Ortiz and I. Meza
Regression to the Mean: Implications for Clinical Trials of Psychotropic Agents in Dementia
Journal:
Current Alzheimer Research
Volume:
1
Page:
323-328
Author(s):
Jeffrey L. Cummings, Rochelle E. Tractenberg, Anthony Gamst, Linda Teri, Donna Masterman and Leon J. Thal